(ASML) ASML Holding - Overview
Sector: TechnologyIndustry: Semiconductor Equipment & Materials | Exchange AS (Netherlands) | Currency EUR | Market Cap: 506.309m | Total Return 81.2% in 12m
Stock: Lithography, Metrology, Inspection
Total Rating 75
Risk 97
Buy Signal 0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 39.4% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.94 |
| Alpha | 78.37 |
| Character TTM | |
|---|---|
| Beta | 1.113 |
| Beta Downside | 0.366 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.77% |
| CAGR/Max DD | 0.68 |
EPS (Earnings per Share)
Revenue
Description: ASML ASML Holding March 05, 2026
ASML Holding N.V. (ASML) provides lithography solutions essential for semiconductor manufacturing. Its offerings include extreme ultraviolet (EUV) and deep ultraviolet (DUV) lithography systems, which are critical for patterning integrated circuits on silicon wafers. The company also supplies metrology and inspection systems to ensure wafer quality, along with computational lithography and control software.
ASML operates within the Semiconductor Materials & Equipment sub-industry, a sector characterized by high capital expenditure and a reliance on advanced technological innovation. Its business model involves selling and servicing complex equipment to chipmakers globally, with a significant presence in Asia, Europe, and the United States.
To gain further insights into ASMLs performance and market position, consider exploring its detailed financials on ValueRay.
Headlines to watch out for
- Chip demand drives lithography equipment sales
- EUV technology leadership maintains market dominance
- Geopolitical tensions impact China sales
- Semiconductor industry cycles affect order book
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 9.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 3.24 > 1.0 |
| NWC/Revenue: 19.45% < 20% (prev 37.81%; Δ -18.36% < -1%) |
| CFO/TA 0.26 > 3% & CFO 13.26b > Net Income 9.61b |
| Net Debt (-10.21b) to EBITDA (12.41b): -0.82 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (387.0m) vs 12m ago -1.68% < -2% |
| Gross Margin: 52.83% > 18% (prev 0.51%; Δ 5.23k% > 0.5%) |
| Asset Turnover: 65.89% > 50% (prev 58.17%; Δ 7.72% > 0%) |
| Interest Coverage Ratio: 96.25 > 6 (EBITDA TTM 12.41b / Interest Expense TTM 118.3m) |
Altman Z'' 4.10
| A: 0.13 (Total Current Assets 30.62b - Total Current Liabilities 24.26b) / Total Assets 50.57b |
| B: 0.35 (Retained Earnings 17.59b / Total Assets 50.57b) |
| C: 0.23 (EBIT TTM 11.39b / Avg Total Assets 49.58b) |
| D: 0.57 (Book Value of Equity 17.59b / Total Liabilities 30.95b) |
| Altman-Z'' Score: 4.10 = AA |
Beneish M -3.26
| DSRI: 0.66 (Receivables 4.17b/5.44b, Revenue 32.67b/28.26b) |
| GMI: 0.97 (GM 52.83% / 51.28%) |
| AQI: 1.06 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.16 (Revenue 32.67b / 28.26b) |
| TATA: -0.07 (NI 9.61b - CFO 13.26b) / TA 50.57b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of ASML shares?
As of March 26, 2026, the stock is trading at EUR 1211.60 with a total of 812,993 shares traded.
Over the past week, the price has changed by +1.73%, over one month by -5.96%, over three months by +33.79% and over the past year by +81.18%.
Over the past week, the price has changed by +1.73%, over one month by -5.96%, over three months by +33.79% and over the past year by +81.18%.
Is ASML a buy, sell or hold?
ASML Holding has no consensus analysts rating.
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1400.4 | 15.6% |
| Analysts Target Price | - | - |
ASML Fundamental Data Overview March 21, 2026
Market Cap USD = 506.31b (437.91b EUR * 1.1562 EUR.USD)
P/E Trailing = 45.7502
P/E Forward = 38.1679
P/S = 13.4051
P/B = 22.1713
P/EG = 2.1629
Revenue TTM = 32.67b EUR
EBIT TTM = 11.39b EUR
EBITDA TTM = 12.41b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortLongTermDebt, last quarter)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.21b EUR (from netDebt column, last quarter)
Enterprise Value = 427.30b EUR (437.91b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = 96.25 (Ebit TTM 11.39b / Interest Expense TTM 118.3m)
EV/FCF = 38.53x (Enterprise Value 427.30b / FCF TTM 11.09b)
FCF Yield = 2.60% (FCF TTM 11.09b / Enterprise Value 427.30b)
FCF Margin = 33.94% (FCF TTM 11.09b / Revenue TTM 32.67b)
Net Margin = 29.42% (Net Income TTM 9.61b / Revenue TTM 32.67b)
Gross Margin = 52.83% ((Revenue TTM 32.67b - Cost of Revenue TTM 15.41b) / Revenue TTM)
Gross Margin QoQ = 52.16% (prev 51.63%)
Tobins Q-Ratio = 8.45 (Enterprise Value 427.30b / Total Assets 50.57b)
Interest Expense / Debt = 4.37% (Interest Expense 118.3m / Debt 2.71b)
Taxrate = 17.89% (618.7m / 3.46b)
NOPAT = 9.35b (EBIT 11.39b * (1 - 17.89%))
Current Ratio = 1.26 (Total Current Assets 30.62b / Total Current Liabilities 24.26b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.61b)
Debt / EBITDA = -0.82 (Net Debt -10.21b / EBITDA 12.41b)
Debt / FCF = -0.92 (Net Debt -10.21b / FCF TTM 11.09b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.38% (Net Income 9.61b / Total Assets 50.57b)
RoE = 52.14% (Net Income TTM 9.61b / Total Stockholder Equity 18.43b)
RoCE = 53.86% (EBIT 11.39b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 292.3% (NOPAT 9.35b / Invested Capital 3.20b)
WACC = 9.86% (E(437.91b)/V(440.62b) * Re(9.90%) + D(2.71b)/V(440.62b) * Rd(4.37%) * (1-Tc(0.18)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.87%
[DCF] Terminal Value 66.76% ; FCFF base≈10.29b ; Y1≈7.97b ; Y5≈5.07b
[DCF] Fair Price = 211.4 (EV 71.29b - Net Debt -10.21b = Equity 81.49b / Shares 385.4m; r=9.86% [WACC]; 5y FCF grow -26.82% → 3.0% )
EPS Correlation: 63.88 | EPS CAGR: 47.02% | SUE: -1.18 | # QB: 0
Revenue Correlation: 76.84 | Revenue CAGR: 30.96% | SUE: 0.94 | # QB: 1
EPS next Quarter (2026-06-30): EPS=6.94 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+8 | Analysts=13
EPS current Year (2026-12-31): EPS=29.69 | Chg7d=+0.000 | Chg30d=+0.161 | Revisions Net=+3 | Growth EPS=+20.2% | Growth Revenue=+15.0%
EPS next Year (2027-12-31): EPS=37.51 | Chg7d=+0.000 | Chg30d=+0.260 | Revisions Net=+4 | Growth EPS=+26.3% | Growth Revenue=+17.1%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.7% (Discount Rate 9.9% - Earnings Yield 2.2%)
[Growth] Growth Spread = +9.0% (Analyst 16.7% - Implied 7.7%)
P/E Trailing = 45.7502
P/E Forward = 38.1679
P/S = 13.4051
P/B = 22.1713
P/EG = 2.1629
Revenue TTM = 32.67b EUR
EBIT TTM = 11.39b EUR
EBITDA TTM = 12.41b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortLongTermDebt, last quarter)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.21b EUR (from netDebt column, last quarter)
Enterprise Value = 427.30b EUR (437.91b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = 96.25 (Ebit TTM 11.39b / Interest Expense TTM 118.3m)
EV/FCF = 38.53x (Enterprise Value 427.30b / FCF TTM 11.09b)
FCF Yield = 2.60% (FCF TTM 11.09b / Enterprise Value 427.30b)
FCF Margin = 33.94% (FCF TTM 11.09b / Revenue TTM 32.67b)
Net Margin = 29.42% (Net Income TTM 9.61b / Revenue TTM 32.67b)
Gross Margin = 52.83% ((Revenue TTM 32.67b - Cost of Revenue TTM 15.41b) / Revenue TTM)
Gross Margin QoQ = 52.16% (prev 51.63%)
Tobins Q-Ratio = 8.45 (Enterprise Value 427.30b / Total Assets 50.57b)
Interest Expense / Debt = 4.37% (Interest Expense 118.3m / Debt 2.71b)
Taxrate = 17.89% (618.7m / 3.46b)
NOPAT = 9.35b (EBIT 11.39b * (1 - 17.89%))
Current Ratio = 1.26 (Total Current Assets 30.62b / Total Current Liabilities 24.26b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.61b)
Debt / EBITDA = -0.82 (Net Debt -10.21b / EBITDA 12.41b)
Debt / FCF = -0.92 (Net Debt -10.21b / FCF TTM 11.09b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.38% (Net Income 9.61b / Total Assets 50.57b)
RoE = 52.14% (Net Income TTM 9.61b / Total Stockholder Equity 18.43b)
RoCE = 53.86% (EBIT 11.39b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 292.3% (NOPAT 9.35b / Invested Capital 3.20b)
WACC = 9.86% (E(437.91b)/V(440.62b) * Re(9.90%) + D(2.71b)/V(440.62b) * Rd(4.37%) * (1-Tc(0.18)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.87%
[DCF] Terminal Value 66.76% ; FCFF base≈10.29b ; Y1≈7.97b ; Y5≈5.07b
[DCF] Fair Price = 211.4 (EV 71.29b - Net Debt -10.21b = Equity 81.49b / Shares 385.4m; r=9.86% [WACC]; 5y FCF grow -26.82% → 3.0% )
EPS Correlation: 63.88 | EPS CAGR: 47.02% | SUE: -1.18 | # QB: 0
Revenue Correlation: 76.84 | Revenue CAGR: 30.96% | SUE: 0.94 | # QB: 1
EPS next Quarter (2026-06-30): EPS=6.94 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+8 | Analysts=13
EPS current Year (2026-12-31): EPS=29.69 | Chg7d=+0.000 | Chg30d=+0.161 | Revisions Net=+3 | Growth EPS=+20.2% | Growth Revenue=+15.0%
EPS next Year (2027-12-31): EPS=37.51 | Chg7d=+0.000 | Chg30d=+0.260 | Revisions Net=+4 | Growth EPS=+26.3% | Growth Revenue=+17.1%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.7% (Discount Rate 9.9% - Earnings Yield 2.2%)
[Growth] Growth Spread = +9.0% (Analyst 16.7% - Implied 7.7%)